KR101672554B1 - Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편 - Google Patents

Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편 Download PDF

Info

Publication number
KR101672554B1
KR101672554B1 KR1020107008765A KR20107008765A KR101672554B1 KR 101672554 B1 KR101672554 B1 KR 101672554B1 KR 1020107008765 A KR1020107008765 A KR 1020107008765A KR 20107008765 A KR20107008765 A KR 20107008765A KR 101672554 B1 KR101672554 B1 KR 101672554B1
Authority
KR
South Korea
Prior art keywords
amino acid
seq
virus
leu
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020107008765A
Other languages
English (en)
Korean (ko)
Other versions
KR20100074212A (ko
Inventor
스테펜 쿠삭
델파인 길리게이
다렌 하르트
프랑 타렌두이
Original Assignee
유럽피안 몰레큘러 바이올로지 래보러토리
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유럽피안 몰레큘러 바이올로지 래보러토리 filed Critical 유럽피안 몰레큘러 바이올로지 래보러토리
Publication of KR20100074212A publication Critical patent/KR20100074212A/ko
Application granted granted Critical
Publication of KR101672554B1 publication Critical patent/KR101672554B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Rigid or semi-rigid containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material or by deep-drawing operations performed on sheet material
    • B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B65D1/0223—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by shape
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2501/00—Containers having bodies formed in one piece
    • B65D2501/0009—Bottles or similar containers with necks or like restricted apertures designed for pouring contents
    • B65D2501/0018—Ribs
    • B65D2501/0036—Hollow circonferential ribs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Ceramic Engineering (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers Having Bodies Formed In One Piece (AREA)
KR1020107008765A 2007-10-09 2008-10-09 Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편 Expired - Fee Related KR101672554B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US99839807P 2007-10-09 2007-10-09
US60/998,398 2007-10-09
US7079208P 2008-03-25 2008-03-25
US61/070,792 2008-03-25
US12345608P 2008-04-08 2008-04-08
US61/123,456 2008-04-08
PCT/EP2008/008543 WO2009046983A1 (en) 2007-10-09 2008-10-09 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap

Publications (2)

Publication Number Publication Date
KR20100074212A KR20100074212A (ko) 2010-07-01
KR101672554B1 true KR101672554B1 (ko) 2016-11-03

Family

ID=40364724

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107008765A Expired - Fee Related KR101672554B1 (ko) 2007-10-09 2008-10-09 Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편

Country Status (11)

Country Link
US (1) US9045248B2 (cg-RX-API-DMAC7.html)
EP (2) EP2574619A3 (cg-RX-API-DMAC7.html)
JP (3) JP5725861B2 (cg-RX-API-DMAC7.html)
KR (1) KR101672554B1 (cg-RX-API-DMAC7.html)
CN (1) CN101970465B (cg-RX-API-DMAC7.html)
AU (1) AU2008309939B2 (cg-RX-API-DMAC7.html)
CA (1) CA2701362A1 (cg-RX-API-DMAC7.html)
ES (1) ES2454773T3 (cg-RX-API-DMAC7.html)
IL (3) IL204891A (cg-RX-API-DMAC7.html)
SG (1) SG185289A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009046983A1 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101672554B1 (ko) 2007-10-09 2016-11-03 유럽피안 몰레큘러 바이올로지 래보러토리 Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
EP2547696B1 (en) * 2010-03-16 2018-05-23 European Molecular Biology Laboratory (Embl) Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
CA2879443A1 (en) * 2012-07-19 2014-01-23 Zoetis Llc Bovine influenza virus compositions
HUE038820T2 (hu) 2013-11-13 2018-11-28 Vertex Pharma Eljárás influenzavírusok replikációjának inhibitorai elõállítására
PT3068776T (pt) 2013-11-13 2019-08-26 Vertex Pharma Inibidores da replicação de vírus da gripe
CN105002149B (zh) * 2014-04-22 2018-04-06 中国科学院生物物理研究所 流感病毒rna聚合酶纯化或结晶的方法
CN105018441A (zh) * 2014-04-22 2015-11-04 中国科学院生物物理研究所 流感病毒rna聚合酶结晶的方法
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
CN107286044B (zh) 2016-04-13 2021-07-13 香港神农有限公司 一种能够抑制流感病毒pb2蛋白与rna帽结合的化合物
CL2018003871A1 (es) 2018-12-28 2021-01-15 Univ Pontificia Catolica Chile Anticuerpos monoclonales específicos para el antígeno pb2 del virus de la influenza humana (flu), secuencias nucleotídicas; método y kit de diagnóstico de infección producida por flu
WO2020239822A1 (en) 2019-05-27 2020-12-03 The European Molecular Biology Laboratory Nucleic acid construct binding to influenza polymerase pb1 rna synthesis active site
CN113122596B (zh) * 2020-08-20 2023-01-24 深圳市瑞吉生物科技有限公司 一种Cap2结构5′帽子类似物及其制备方法和应用
CN114741315B (zh) * 2022-04-28 2023-06-13 深圳市紫光同创电子有限公司 用例更新方法、装置、电子设备及存储介质
CN116024301B (zh) * 2023-01-16 2025-10-28 北京协同创新研究院 一种rna依赖性rna聚合酶截短体的筛选方法、截短体及应用
WO2025055169A1 (en) * 2023-09-12 2025-03-20 The Chinese University Of Hong Kong A fluorescent probe to measure rna binding and elongation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837852A (en) * 1993-10-14 1998-11-17 Bristol-Myers Squibb Company Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease
KR101672554B1 (ko) * 2007-10-09 2016-11-03 유럽피안 몰레큘러 바이올로지 래보러토리 Rna 캡에 결합 가능한 인플루엔자 바이러스 pb2 단백질의 가용성 단편
JP6614523B2 (ja) * 2014-03-28 2019-12-04 地方独立行政法人神奈川県立産業技術総合研究所 インフルエンザウイルスのrna依存性rnaポリメラーゼのpb2サブユニットに対するモノクローナル抗体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Ayae Honda 등. Genes to Cells Vol. 4, No. 8, 페이지 475-485 (1999.)*
Pierre Fechter 등. J. Biol. Chem. Vol. 278, No. 22, 페이지 20381-20388 (2003.)*
Pierre Fechter 등. J. Gen. Virol. Vol. 86, No. 5, 페이지 1239-1249 (2005.)*

Also Published As

Publication number Publication date
EP2197901A1 (en) 2010-06-23
CA2701362A1 (en) 2009-04-16
CN101970465A (zh) 2011-02-09
EP2197901B1 (en) 2013-12-11
JP2015062417A (ja) 2015-04-09
IL222997A0 (en) 2012-12-31
EP2574619A2 (en) 2013-04-03
IL204891A0 (en) 2010-11-30
AU2008309939B2 (en) 2013-11-14
JP6309563B2 (ja) 2018-04-11
SG185289A1 (en) 2012-11-29
JP2016176955A (ja) 2016-10-06
ES2454773T3 (es) 2014-04-11
JP2011501942A (ja) 2011-01-20
US9045248B2 (en) 2015-06-02
IL237903A (en) 2017-10-31
JP5937169B2 (ja) 2016-06-22
KR20100074212A (ko) 2010-07-01
US20110008348A1 (en) 2011-01-13
CN101970465B (zh) 2016-03-16
AU2008309939A1 (en) 2009-04-16
WO2009046983A1 (en) 2009-04-16
EP2574619A3 (en) 2013-07-31
JP5725861B2 (ja) 2015-05-27
IL204891A (en) 2015-04-30

Similar Documents

Publication Publication Date Title
EP2197901B1 (en) Soluble fragments of influenza virus pb2 protein capable of binding rna-cap
US20180010109A1 (en) Polypeptide fragments comprising endonuclease activity and their use
US20180044649A1 (en) Influenza a 2009 pandemic h1n1 polypeptide fragments comprising endonuclease activity and their use
HK1179985A (en) Soluble fragments of influenza virus pb2 protein capable of binding rna-cap
HK1183501A (en) Polypeptide fragments comprising endonuclease activity and their use
HK1163166B (en) Polypeptide fragments comprising endonuclease activity and their use
HK1163166A (en) Polypeptide fragments comprising endonuclease activity and their use

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P18-X000 Priority claim added or amended

St.27 status event code: A-2-2-P10-P18-nap-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

FPAY Annual fee payment

Payment date: 20191018

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20201029

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20201029